Ichiro Takada
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Integrating Molecular Classification Based on FGFR3, KRAS, HRAS, and TP53 Mutation With TNM Staging Modestly Improves Prediction of Prognosis of Upper Tract Urothelial Carcinoma After Surgery.
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: May 04, 2026
Pathophysiology of Semen Parameter Deterioration Associated with Varicocele --Evaluation of Total Antioxidant Capacity in Seminal Plasma and Serum-
Journal: Hinyokika kiyo. Acta urologica Japonica
Published: June 05, 2025
Transglutaminase 2 Stimulates Cell Proliferation and Modulates Transforming Growth Factor-Beta Signaling Pathway Independently of Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells.
Journal: International journal of molecular sciences
Published: April 19, 2025
The Role of ESS2/DGCR14: Is It an Essential Factor in Splicing and Transcription?
Journal: International journal of molecular sciences
Published: March 14, 2025
Recent advances in prostate cancer: WNT signaling, chromatin regulation, and transcriptional coregulators.
Journal: Asian journal of andrology
Published: January 25, 2023
ESS2 controls prostate cancer progression through recruitment of chromodomain helicase DNA binding protein 1.
Journal: Scientific reports
Published: November 15, 2022
Transcriptional coregulator Ess2 controls survival of post-thymic CD4+ T cells through the Myc and IL-7 signaling pathways.
Journal: The Journal of biological chemistry
Published: December 29, 2021
FGFR2 loss sensitizes MYCN-amplified neuroblastoma CHP134 cells to CHK1 inhibitor-induced apoptosis.
FGFR2 loss sensitizes MYCN-amplified neuroblastoma CHP134 cells to CHK1 inhibitor-induced apoptosis.
Journal: Cancer science
Published: January 03, 2021
Peroxisome proliferator-activated receptor agonists and antagonists: a patent review (2014-present).
Peroxisome proliferator-activated receptor agonists and antagonists: a patent review (2014-present).
Journal: Expert opinion on therapeutic patents
Published: December 12, 2019
Farnesoid X Receptor Activation Enhances Transforming Growth Factor β-Induced Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells.
Journal: International journal of molecular sciences
Published: May 26, 2018
Ess2 bridges transcriptional regulators and spliceosomal complexes via distinct interacting domains.
Ess2 bridges transcriptional regulators and spliceosomal complexes via distinct interacting domains.
Journal: Biochemical and biophysical research communications
Published: January 31, 2018
Last Updated: 09/26/2026